These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology. Gabrielsson J; Green AR J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129 [TBL] [Abstract][Full Text] [Related]
6. Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling. Keller F; Czock D; Zellner D; Giehl M Int J Clin Pharmacol Ther; 1998 Mar; 36(3):168-75. PubMed ID: 9562234 [TBL] [Abstract][Full Text] [Related]
7. Primer on clinical pharmacokinetics. Bauer LA Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025 [TBL] [Abstract][Full Text] [Related]
8. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Meibohm B; Derendorf H Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388 [TBL] [Abstract][Full Text] [Related]
9. Predictors of onset and offset of drug effect. Schnider TW; Minto CF Eur J Anaesthesiol Suppl; 2001; 23():26-31. PubMed ID: 11766242 [TBL] [Abstract][Full Text] [Related]
10. A primer on pharmacokinetics. Quan DJ Nephrol Nurs J; 2008; 35(2):213-5. PubMed ID: 18472692 [TBL] [Abstract][Full Text] [Related]
11. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models. Lowe PJ; Tannenbaum S; Wu K; Lloyd P; Sims J Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):195-209. PubMed ID: 20050847 [TBL] [Abstract][Full Text] [Related]
12. Review on correlation between pharmacologic response and drug disposition. Ritschel WA; Hussain A Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):627-40. PubMed ID: 6392792 [TBL] [Abstract][Full Text] [Related]
13. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles]. Klotz U J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441 [TBL] [Abstract][Full Text] [Related]
15. Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance. Boissel JP; Nony P Clin Pharmacokinet; 2002; 41(1):1-6. PubMed ID: 11825093 [TBL] [Abstract][Full Text] [Related]
16. Models for assessing the relationship between drug concentration and drug effect in performance horses. Kamerling SG; Owens JG Br Vet J; 1994; 150(6):507-25. PubMed ID: 7850442 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma. Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371 [TBL] [Abstract][Full Text] [Related]
18. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Schwartz JB Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875 [TBL] [Abstract][Full Text] [Related]
19. Prediction of the volume of distribution from in vitro data and use for estimating the absolute extent of absorption. Ritschel WA; Hammer GV Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):298-316. PubMed ID: 7429676 [TBL] [Abstract][Full Text] [Related]
20. [Absorption and biological availability of drugs]. Uribe M Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]